您的位置：首页 > 产品中心 > PEO1
产品性质
| biological source【生物来源】 | human ovary |
| growth mode【生长模式】 | Adherent |
| karyotype【核型】 | For modal chromosome numbers see Langdon SP et.al. (1988) Cancer Research Nov 1; 48(21):6166-72. |
| morphology【形态学】 | Epithelial; islands of uniform polygonal cells. |
| products【产品】 | Not specified |
| receptors【受体】 | Oestrogen receptor positive cell line. For antigen expression see Langdon SP et.al. (1988) Cancer Research Nov 1; 48(21):6166-72. |
| technique(s) | cell culture | mammalian: suitable |
| relevant disease(s)【相关疾病】 | cancer |
| shipped in【运输】 | dry ice |
| storage temp.【储存温度】 | −196℃ |
基本信息
| Cell Line Origin【细胞系来源】 | Human ovarian cancer; oestrogen receptor positive |
| DNA Profile【DNA图谱分析】 | STR-PCR Data: Amelogenin: X CSF1PO: 10,12 D13S317: 10 D16S539: 9 D5S818: 11,12 D7S820: 10 THO1: 9.3 TPOX: 9,11 vWA: 15,16 |
| Culture Medium【培养基】 | RPMI -1640 + 2mM Glutamine + 2mM Sodium Pyruvate + 10% Foetal Bovine Serum (FBS). |
| Subculture Routine【传代培养常规】 | Split sub-confluent cultures (70-80%) 1:4 to 1:10 seeding at 2- 3 x 104 cells/cm2 using 0.05% trypsin or trypsin/EDTA; 5% CO2; 37℃. Doubling time approximately 37 hours. |
| Other Notes【其他说明】 | Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information. |
产品说明
| Disclaimer【免责声明】 | This cell line has special release conditions: Commercial organisations are required to complete the ′Cell Line Release Authorisation for Research Use in Commercial Organisations′ release conditions form. |
